Received: 25 August 2020
Revised: 11 November 2020
Accepted: 25 November 2020
First Online: 4 January 2021
Ethics approval and consent to participate
: All participants gave written informed consent to participate in the study. The study was approved by the National Research Ethics Service Committee London—Chelsea (REC reference 11/LO/1598). The study was performed in accordance with the Declaration of Helsinki.
: No individual patient data are included in this article that could be used to identify any individual.
: The data from this study are available via the Institute of Cancer Research’s XNAT imaging data repository. Access requests will be granted depending on appropriate regulatory and institutional approvals upon contacting the corresponding author.
: The authors declare no competing interests.
: We acknowledge funding from Cancer Research UK BIDD grant C1353/A12762 and Cancer Research UK and Engineering and Physical Sciences Research Council support to the Cancer Imaging Centre at the Institute of Cancer Research and Royal Marsden Hospital in association with the Medical Research Council and Department of Health C1060/A10334, C1060/A16464 and National Health Service funding to the National Institute for Health Research Biomedical Research Centres at Royal Marsden Hospital/Institute of Cancer Research and Cambridge, Experimental Cancer Medicine Centres, the Clinical Research Facility in Imaging, and the Cancer Research Network. We are also grateful for financial support from Addenbrooke’s Charitable Trust. The views expressed in this publication are those of the author(s) and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health.